Education
About Us
Working with TipRanks
Follow Us
Neola Medical AB (SE:NEOLA)
:NEOLA
Total Valuation
Neola Medical AB has a market cap or net worth of kr67.50M. The enterprise value is kr51.38M.
Market Capkr67.50M
Enterprise Valuekr51.38M
Share Statistics
Neola Medical AB has 77,950,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding77,950,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neola Medical AB’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.69%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-14.69%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee0.00
Profits Per Employee-1.57M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neola Medical AB is ―. Neola Medical AB’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio1.07
Price to Fair Value1.07
Price to FCF0.00
Price to Operating Cash Flow-5.74
PEG Ratio0.00
Income Statement
In the last 12 months, Neola Medical AB had revenue of 0.00 and earned -11.02M in profits. Earnings per share was -0.14.
Revenue0.00
Gross Profit-1.39M
Operating Income-11.14M
Pretax Income-11.02M
Net Income-11.02M
EBITDA-9.75M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was -8.54M and capital expenditures 8.54M, giving a free cash flow of -2.54M billion.
Operating Cash Flow-8.54M
Free Cash Flow-2.54M
Free Cash Flow per Share-0.03
Dividends & Yields
Neola Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.03
52-Week Price Change-62.99%
50-Day Moving Average0.95
200-Day Moving Average1.80
Relative Strength Index (RSI)49.06
Average Volume (3m)12.79K
Important Dates
Neola Medical AB upcoming earnings date is May 27, 2026, Before Open (Confirmed).
Last Earnings DateFeb 12, 2026
Next Earnings DateMay 27, 2026
Ex-Dividend Date―
Financial Position
Neola Medical AB as a current ratio of 5.75, with Debt / Equity ratio of 0.00%
Current Ratio5.75
Quick Ratio5.75
Debt to Market Cap0.00
Net Debt to EBITDA1.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Neola Medical AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Neola Medical AB EV to EBITDA ratio is -6.68, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-6.68
EV to Free Cash Flow0.00
EV to Operating Cash Flow-5.45
Balance Sheet
Neola Medical AB has kr22.12M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr22.12M billion.
Cash & Marketable Securitieskr22.12M
Total Debtkr0.00
Net Cashkr22.12M
Net Cash Per Sharekr0.28
Tangible Book Value Per Sharekr0.99
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Neola Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―